EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study

Alireza Bahrami, Shirin Haghighi, Mona Malekzadeh Moghani, Nastaran Khodakarim, Ehsan Hejazi

Frontiers in Nutrition · 04.12.2024 · 11

DOI: 10.3389/fnut.2024.1483707 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Nutrition, online erschienen am 04.12.2024. Verfasst von Alireza Bahrami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition and Dietetics, School of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Teh…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Preclinical evidences suggests that while fasting can reduce the side effects and toxicity of chemotherapy, it can make cancer cells more susceptible to chemotherapy. This study aimed to examine the effects of fasting mimicking diet (FMD) during neo-adjuvant chemotherapy in breast cancer (BC) patients.

Methods

Forty-four newly diagnosed human epidermal growth factor receptor 2-negative (HER2-negative) patients with BC were randomized equally into two groups (22 each), to receive either a fasting mimicking diet (FMD) or their regular diet for 3 days prior to and during neoadjuvant chemotherapy. This FMD was repeated every 3 weeks for 8 cycles. Efficacy, toxicity, hematologic, metabolic, and inflammatory parameters were measured and compared.

Results

The occurrence of grade III vomiting and neutropenia in the control group was significantly higher than the FMD group ( P = <0.001 and p = 0.04 respectively). Erythrocytes ( p = 0.01) and neutrophils ( p = 0.002) counts were significantly higher in FMD group compared to control group after cycle 8. There was a significant increase in median glucose and median insulin levels ( p = 0.01 and p = 0.005, respectively) in the control group between baseline and after cycle 8. While, the median Insulin-like growth factor-1 (IGF1) ( p = 0.006) and hs-CRP ( p = 0.02) levels were significantly decreased in the FMD group. At the end of study (after cycle 8), the median glucose level was significantly higher in control group ( p = 0.008), while the median hs-CRP level was significantly lower in FMD group ( p = 0.01). The Miller and Payne pathological response 4/5 (90–100% tumor cell loss) and the radiologically complete or partial response, as measured by MRI or ultrasound before surgery occurred more frequently in FMD group compared to the controls ( p = 0.01).

Conclusion

Fasting mimicking diet was well tolerated during chemotherapy and reduced toxicity of chemotherapy and also, had beneficial effects of some metabolic parameters. Clinical Trial Registration https://irct.behdasht.gov.ir/user/trial/61386/view .

Schlagwörter

Stichwörter der Autor:innen

breast cancerchemotherapyfastingfasting mimicking diettoxicity

Autor:innen und Institutionen

  • Department of Clinical Nutrition and Dietetics, School of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Oncology, Gastroenterology and Liver Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Radiation Oncology, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Hematology & Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Bahrami, A., Haghighi, S., Moghani, M. M., Khodakarim, N., & Hejazi, E. (2024). Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1483707

Vancouver

Bahrami A, Haghighi S, Moghani MM, Khodakarim N, Hejazi E. Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study. Frontiers in Nutrition. 2024;11. doi:10.3389/fnut.2024.1483707

BibTeX
@article{Bahrami2024,
  author = {Bahrami, Alireza and Haghighi, Shirin and Moghani, Mona Malekzadeh and Khodakarim, Nastaran and Hejazi, Ehsan},
  title = {Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study},
  journal = {Frontiers in Nutrition},
  year = {2024},
  volume = {11},
  doi = {10.3389/fnut.2024.1483707}
}
Kostenlos starten →